Serum neurofilament light levels correlate with severity measures and neurodegeneration markers in autosomal dominant Alzheimer's disease.
Raquel Sanchez-ValleAmanda HeslegraveMartha S FoianiBeatriz BoschAnna AntonellMircea BalasaAlbert LladóHenrik ZetterbergNick C FoxPublished in: Alzheimer's research & therapy (2018)
Serum NfL might be a feasible non-invasive biomarker to track disease onset and severity in ADAD.
Keyphrases